KURA Kura Oncology Inc

Title of Securities to be Registered

Amount

to be

Registered ⁽¹⁾

Proposed Maximum

Offering Price

Per Share ⁽²⁾

Proposed Maximum

Aggregate

Offering Price ⁽²⁾

Amount of

Registration Fee

Amended and Restated 2014 Equity Incentive Plan
Common Stock, $0.0001 par value per share

1,525,906 ⁽³⁾

$15.19

$23,178,512

$2,809.24

Total

1,525,906

$15.19

$23,178,512

$2,809.24

(1)

Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover any additional shares of the Registrant’s Common Stock (“Common Stock”) that become issuable under the Kura Oncology, Inc. Amended and Restated 2014 Equity Incentive Plan (the “2014 Plan”) by reason of any stock dividend, stock split, recapitalization or other similar transaction.

(2)

This estimate is made pursuant to Rule 457(h)(1) and Rule 457(c) of the Securities Act solely for purposes of calculating the registration fee. The price per share and aggregate offering price are based upon the average of the high and low prices of the Common Stock on March 4, 2019, as reported on the Nasdaq Global Select Market.

(3)

Represents shares of Common Stock that were automatically added to the shares authorized for issuance under the 2014 Plan on January 1, 2019 pursuant to an “evergreen” provision contained in the 2014 Plan. Pursuant to such provision, on January 1 of each year through January 1, 2025 , the number of shares authorized for issuance under the 2014 Plan is automatically increased by: (a) a number equal to 4% of the total number of shares of the Registrant’s capital stock outstanding on December 31 of the preceding calendar year; or (b) a number of shares of Common Stock that may be determined by the Registrant’s Board of Directors that is less than the preceding clause (a).